BR0014052A - Amine derivatives - Google Patents

Amine derivatives

Info

Publication number
BR0014052A
BR0014052A BR0014052-0A BR0014052A BR0014052A BR 0014052 A BR0014052 A BR 0014052A BR 0014052 A BR0014052 A BR 0014052A BR 0014052 A BR0014052 A BR 0014052A
Authority
BR
Brazil
Prior art keywords
amine derivatives
ring
solvates
inhibition
therapy
Prior art date
Application number
BR0014052-0A
Other languages
Portuguese (pt)
Inventor
Volker Eiermann
Rochus Jonas
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0014052A publication Critical patent/BR0014052A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "DERIVADOS DE AMINAS". e seus sais e solvatos fisiologicamente aceitáveis, em que R^ 1^, R^ 2^, R^ 8^, R^ 9^, R^ 10^, R^ 11^, Q, X, Y, Z, r, o anel A e o anel C têm as definições estabelecidas na reivindicação 1, apresentam inibição de fosfodiesterase V e podem ser utilizados para tratar distúrbios do sistema cardiovascular e para o tratamento e/ou terapia da potência prejudicada.Invention Patent: "AMIN DERIVATIVES". and their physiologically acceptable salts and solvates, where R ^ 1 ^, R ^ 2 ^, R ^ 8 ^, R ^ 9 ^, R ^ 10 ^, R ^ 11 ^, Q, X, Y, Z, r, ring A and ring C have the definitions set out in claim 1, exhibit phosphodiesterase V inhibition and can be used to treat disorders of the cardiovascular system and for the treatment and / or therapy of impaired potency.

BR0014052-0A 1999-09-17 2000-08-24 Amine derivatives BR0014052A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944604A DE19944604A1 (en) 1999-09-17 1999-09-17 Amine derivatives
PCT/EP2000/008256 WO2001021620A2 (en) 1999-09-17 2000-08-24 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines

Publications (1)

Publication Number Publication Date
BR0014052A true BR0014052A (en) 2002-05-21

Family

ID=7922374

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014052-0A BR0014052A (en) 1999-09-17 2000-08-24 Amine derivatives

Country Status (11)

Country Link
EP (1) EP1212329A2 (en)
JP (1) JP2003509511A (en)
KR (1) KR20020027652A (en)
AU (1) AU7412700A (en)
BR (1) BR0014052A (en)
CA (1) CA2387520A1 (en)
CZ (1) CZ2002817A3 (en)
DE (1) DE19944604A1 (en)
NO (1) NO20021310D0 (en)
PL (1) PL353319A1 (en)
WO (1) WO2001021620A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10148883A1 (en) 2001-10-04 2003-04-10 Merck Patent Gmbh New fused bi- or tricyclic pyrimidine derivatives, are phosphodiesterase V inhibitors useful e.g. for treating impotence, cardiovascular disorders, inflammation or tumors
WO2003035653A1 (en) * 2001-10-26 2003-05-01 Nippon Soda Co.,Ltd. Pyridothienopyrimidine compound and salt thereof
AR059901A1 (en) 2006-03-20 2008-05-07 Bayer Pharmaceuticals Corp USEFUL TETRAHYDROPIRIDOTIENOPIRIMIDINE COMPOUNDS TO TREAT OR PREVENT CELLULAR PROLIFERATIVE DISORDERS.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470356A1 (en) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K New thieno [3,2-d] pyrimidines and process for their preparation
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (en) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidines
DE19819023A1 (en) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidines
US5948911A (en) * 1998-11-20 1999-09-07 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
CN1346358A (en) * 1999-03-30 2002-04-24 日本曹达株式会社 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
DE19928146A1 (en) * 1999-06-19 2000-12-21 Merck Patent Gmbh New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence

Also Published As

Publication number Publication date
NO20021310L (en) 2002-03-15
WO2001021620A2 (en) 2001-03-29
AU7412700A (en) 2001-04-24
KR20020027652A (en) 2002-04-13
CZ2002817A3 (en) 2002-06-12
DE19944604A1 (en) 2001-03-22
PL353319A1 (en) 2003-11-17
NO20021310D0 (en) 2002-03-15
EP1212329A2 (en) 2002-06-12
CA2387520A1 (en) 2001-03-29
JP2003509511A (en) 2003-03-11
WO2001021620A3 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
BR9712321A (en) Aminothiophenocarboxamides
BR9901491A (en) 7-hetero-bicycles [2.2.1] - heptanes.
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BR9815409A (en) Thienopyrimidines
NO20050807L (en) Pharmaceutical compositions including dextromethorphan and quinidine for the treatment of neurological disorders
BR0109272A (en) Therapeutic conjugate agents of polyglutamic acid, methods for their preparation and uses
BG108268A (en) Pyrazolopyrimidines as therapeutic agents
BR0309875A (en) methods and compositions for treating peripheral nervous system disorders and novel compounds useful therefor
MY103352A (en) Piperazinyl-heterocyclic compounds
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
BR0014381A (en) Derivatives of 5-beta-sapogenin and pseudosapogenin and their use in the treatment of dementia
BR0210652A (en) Pyrrolopyrimidines as protein kinase inhibitors
BR0209153A (en) Indole, azaindole and related heterocyclic amidopiperazine derivatives
BR0313732A (en) Pyrimide compounds having antiproliferative activity
GB0005251D0 (en) Therapeutic compounds
BR9814592A (en) "azopolycyclic compounds condensed with aryl"
HK1050899A1 (en) Pteridine compounds for the treatment of psoriasis
AP9701041A0 (en) Pyridylpyrrole compounds.
BR0011778A (en) Thienopyrimidines
BR0312232A (en) Caspase inhibitors and their uses
BR0013781A (en) Pyrazolo [4,3-d] pyrimidines
MXPA03010761A (en) Pharmaceutical combinations.
BR0113291A (en) aporphine esters and their use in therapy
BR0014355A (en) Sapogenin derivatives and their use in the treatment of cognitive dysfunction
BR9910032A (en) Thienopyrimidines

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]